1,1,2-trichloro-3,3,3-trifluoro-1-propene: nephrotoxic cpd; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 67938 |
SCHEMBL ID | 242971 |
MeSH ID | M0167533 |
Synonym |
---|
nsc-6824 |
1,2-trichloro-3,3,3-trifluoropropene |
propene,1,2-trichloro-3,3,3-trifluoro- |
1-propene,1,2-trichloro-3,3,3-trifluoro- |
1,1-trifluoro-2,3,3-trichloropropene |
nsc6824 |
431-52-7 |
1,2-trichlorotrifluoro-1-propene |
propene, 1,1,2-trichloro-3,3,3-trifluoro- |
1-propene, 1,1,2-trichloro-3,3,3-trifluoro- |
1,1,2-trichloro-3,3,3-trifluoro-1-propene |
einecs 207-075-0 |
1,1,2-trichloro-3,3,3-trifluoropropene |
7-methylhexahydro-2h-benzo[b][1,4]dioxepin-3(4h)-one |
1,1,2-trichloro-3,3,3-trifluoroprop-1-ene |
h2mq7f3kmq , |
unii-h2mq7f3kmq |
nsc 6824 |
2,3,3-trichloro-1,1,1-trifluoro-2-propene |
trifluorotrichloropropene |
AKOS006229782 |
FT-0605982 |
SCHEMBL242971 |
1,1,2-trichlorotrifluoro-1-propene |
1,1,1-trifluoro-2,3,3-trichloro-2-propene |
1,1,2-trichloro-3,3,3-trifluoropropene-1 |
1,1,2-trichloro-3,3,3-trifluoro-1-propene # |
1,1,1-trifluoro-2,3,3-trichloropropene |
DTXSID8073184 |
mfcd00013672 |
cfc 1213xa |
1,1,2-trichlorotrifluoroprop-1-ene |
Excerpt | Reference | Relevance |
---|---|---|
" A combination of high resolution proton nuclear magnetic resonance (1H NMR) spectroscopy of urine, renal histopathology and more routinely used clinical chemistry methods has been used to explore the acute toxic and biochemical effects of S-(1,2-dichlorovinyl)-L-cysteine (DCVC), S-(1,2-dichlorovinyl)-L-homocysteine (DCVHC) and 1,1,2-trichloro-3,3,3-trifluoro-1-propene (TCTFP) up to 48 h following their administration to male Fischer 344 (F344) rats." | ( Studies on the comparative toxicity of S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2-dichlorovinyl)-L-homocysteine and 1,1,2-trichloro-3,3,3-trifluoro-1-propene in the Fischer 344 rat. Anthony, ML; Beddell, CR; Lindon, JC; Nicholson, JK, 1994) | 0.67 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.56) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |